Main Page   Substance Abuse   Prescription Drug Monitoring Programs   Publications

Publications

Suggested Initial Readings

Department of Health Professions, & Virginia State Police. (2004). Prescription monitoring program. Richmond, VA: Authors.

Simeone, R. & Holland, L. (2006). An evaluation of prescription drug monitoring programs. Albany, New York: Simeone Associates, Inc.

Process Evaluations

Barber, N., Cornford, T., & Klecun, E. (2008). Qualitative evaluation of an electronic prescribing and administration system. Quality of Safe Health Care, 16, 271-278.

Lambert, D. (2006). Evaluation of the implementation of Maine's prescription drug monitoring program. Portland, Maine: Muskie School of Public Service, University of Southern Maine.

Outcome Evaluations

Barrett, K. (2004). Prescription monitoring program survey: Report of findings. Richmond, Virginia: Virginia Commonwealth University, Survey and Evaluation Research Laboratory.

Department of Health Professions, & Virginia State Police. (2004). Prescription monitoring program. Richmond, VA: Authors.

Lambert, D. (2007). Impact evaluation of Maine's Prescription Drug Monitoring Program. Portland, Maine: Muskie School of Public Service, University of Southern Maine.

Parente, S. T., Kim, S. S., Finch, M. D., Schloff, L. A., Rector, T. S., Seifeldin, R., & Haddox, J. D. (2004). Identifying controlled substance patterns of utilization requiring evaluation using administrative data. The American Journal of Managed Care, 10, 11, 783-790.

Rosenblatt, N. (2004). Reducing the diversion of scheduled prescription medications in the Commonwealth of Kentucky: 2004 KASPER Satisfaction Survey: Executive summary. Frankfort, Kentucky: Kentucky Cabinet for Health and Family Services.

Simeone, R. & Holland, L. (2006). An evaluation of prescription drug monitoring programs. Albany, New York: Simeone Associates, Inc.

Tamblyn, R., Huang, A., Kawasumi, Y., Bartlett, G., Grad, R., Jacques, A., Dawes, M., Abrahamowicz, M., Perreault, R., Taylor, L., Winslade, N., Poissant, L., & Pinsonneault, A. (2006). The development and evaluation of an integrated electronic prescribing and drug management system for primary care. Journal of American Medical Information Association, 13, 148-159.

Other Prescription Drug Monitoring Program Reports

Adams, E. H., & Kopstein, A. N. (1993). The nonmedical use of prescription drugs in the United States. Impact of prescription drug diversion control systems on medical practice and patient care, NIDA Research Monograph 131, 109-117.

Alliance of States with Prescription Monitoring Programs. (1999). The goals of prescription monitoring. Waltham, Mass.: Author.

Auditor of the Commonwealth. (2007). Independent state auditor's report on certain activities of the Department of Public Health's drug control program. Boston, Massachusetts: Author.

Brushwood, D. B. (2003). Maximizing the value of electronic prescription monitoring programs. Journal of Law, Medicine & Ethics, 31, 41-54.

Center for Substance Abuse Treatment. (2005). National All Schedules Prescription Electronic Reporting Act of 2005: A review of implementation of existing state controlled substance monitoring programs. Rockville, MD: Author.

Colker, A. C. (2005). Prescription drug abuse. Washington, DC: National Conference of State Legislatures.

Community Antidrug Coalitions of America. (2001). Prescription drug abuse prevention - Where do we go from here? Alexandria, VA: Author.

Fishman, S. M., Papazian, J. S., Gonzalez, S., Riches, P. S., & Gilson, A. (2004). Regulating opiod prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Medicine, 5, 3, 309-324.

Forgione, D. A., Neuenschwander, P., & Vermeer, T. E. (2001). Diversion of prescription drugs to the black market: What the states are doing to curb the tide. Journal of Health Care Finance, 27, (4), 65-78.

General Accounting Office. (2005). Prescription drugs: Strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation. Washington, DC: Author.

IJIS Institute. (2007). PMP Committee Phase II PMIX pilot project survey of state prescription drug monitoring programs. Alexandria, VA: Author.

Joranson, D. E., Carrow, G. M., Ryan, K. M., Schaefer, L., Gilson, A. M., Good, P., Eadie, J., Peine, S., & Dahl, J. L. (2002). Pain management and prescription monitoring. Journal of Pain and Symptom Management, 23, 3, 231-238.

Kraman, P. (2004). Prescription drug diversion. Lexington, KY: The Council of State Governments.

Legislative Research Commission. (2003). Improving Kentucky's prescription drug monitoring program: Ideas and recommendations. Frankfort, Kentucky: Author.

Legislative Research Commission. (2006). Information systems can help prevent, but not eliminate, health care fraud and abuse. Frankfort, Kentucky: Author.

Manchikanti, L., Whitfield, E., & Pallone, F. (2005). Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment. Pain Physician, 8, 335-347.

Massachusetts OxyContin and Other Drug Abuse Commission. (n.d.). OxyContin Commission report. Massachusetts: Author.

Miller, M. M., & Brown, R. T. (2007). Prescription drug monitoring programs. American Family Physician, 75, (6), 1-3.

Rand Corporation. (2005). Electronic prescribing systems: Making it safer to take your medicine? Santa Monica, California: Author.

State of Maryland Office of the Attorney General. (2005). Prescription for disaster: The growing problem of prescription drug abuse in Maryland. Maryland: Author.

Trescott, A. (2007). NASPER: Why has the National All Schedules Prescription Electronic Reporting not been implemented? Gainesville, FL: University of Florida.

United States General Accounting Office. (2004). Prescription drugs: State monitoring programs may help to reduce illegal diversion. Washington, DC: Author.

United States General Accounting Office. (2002). Prescription drugs: State monitoring programs provide useful tool to reduce diversion. Washington, DC: Author.

Wartell, J., & La Vigne, N. G. (2004). Prescription fraud. Washington, DC: Office of Community Oriented Policing Services.